iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis

Jan.14.2025
iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY launches innovative three-tank e-cigarette, iJOY Lio SS40000, with adjustable ice and sweetness levels in the US market.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are only used to depict facts and are not intended as advertisements for any products.

This article prohibits minors from accessing it.


 

iJOY recently launched a new e-cigarette model called the iJOY Lio SS40000, featuring a triple-pod design that allows for adjustable cooling and sweetness levels. The product has already hit the market in the United States.

 

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 | Image source: worldvapeusa

 

Specifically, the product specifications of iJOY Lio SS40000 are as shown in the table below.

iJOY Lio SS40000: Three-Tank Design E-Cigarette Review and Analysis
iJOY Lio SS40000 Product Information | Design: Two to Supreme

 

The main feature of the iJOY Lio SS40000 e-cigarette is its three-pod system design. According to the manufacturer's website, the product includes a total of four ice levels and three sweetness options, allowing users to adjust both independently using two dedicated buttons.

 

In addition, the iJOY Lio SS40000 also features a 3D curved side screen, which can display battery level, e-liquid remaining amount, and monitor information such as ice level and sweetness level.

 

In December, Shenzhen Donghaoxing Technology Co., Ltd.'s e-cigarette brand Artery Vapor also launched a three-pod design e-cigarette, the Artery CL6 Sweet & Ice Control 50K, in the US market. This product also allows for adjusting the level of sweetness and ice. However, compared to the iJOY Lio SS40000, the Artery CL6 Sweet & Ice Control 50K has advantages in terms of the number of puffs and e-liquid capacity. (For more details, please refer to the article "Product | Three-pod design disposable e-cigarette launches in the US, offering adjustable ice and sweetness levels").

 

In the first half of 2024, iJoy has launched the e-cigarette iJoy Bar SD40000 in the United States, which has a capacity of 40,000 puffs. This product is among the first batch of e-cigarettes in the U.S. market to have a puff capacity of 40,000. Up to now, the performance of iJoy's e-cigarette products in terms of puff capacity has not seen any new breakthroughs. (For more details, please refer to "Product | iJoy launches 40,000 puff disposable e-cigarette in the U.S. with support for AI voice control")

 

The iJOY Lio SS40000 has landed on e-cigarette distributor websites such as vapesourcing, midwestgoods, and worldvapeusa, but is currently not available on the official iJOY website.

 


2Firsts will continue to monitor the performance and market trends of global e-cigarette products, providing the public with accurate and authoritative industry information.

 

2FIRSTS is a product column dedicated to providing readers with the latest information on new products in the tobacco industry. In order to collect and share first-hand information from the industry more broadly, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us at info@2firsts.com at any time.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24